Oakstone Cytopathology 2026

Oakstone Cytopathology 2026

Include: 43 videos + 2 pdfs, size: 8.41 GB

+ Target Audience: pathologists needing to improve their understanding and confidence in the diagnosis of cytopathology specimens

+ Information:

Cytopathology to Refine Diagnostic Skills

Take your diagnostic skills to the next level with this engaging, practice-focused online course. Cytopathology — part of our Masters of Pathology Series — reviews the latest updates to WHO reporting systems and explores how molecular testing and other ancillary studies are transforming the way small biopsy and cytopathology specimens are assessed.

Geared towards those who may not have formal training in cytopathology, the succinct, high-yield lectures in this continuing medical education program are divided by specimen type and will help you to:

• Gain a deeper understanding of how The Bethesda System for Reporting Thyroid Cytopathology has reduced unnecessary surgical interventions
• Consistently generate standardized reports that are more useful and better understood by clinicians
• Avoid common pitfalls like overinterpreting benign findings or relying too heavily on surgical pathology when results are discordant
• Confidently identify benign and reactive findings in cytopathology specimens
• And more…

Date of Original Release: January 15, 2026

Learning Objectives

At the completion of this course, you should be able to:

• List ancillary tests that should be ordered on lung specimens when a new diagnosis of non-small cell carcinoma is made
• Describe changes made in the newest version of The Bethesda System for Reporting Thyroid Cytopathology
• Name the diagnostic categories used in The Paris System for Reporting Urinary Cytology
• Understand situations in which a diagnosis of Salivary Gland of Uncertain Malignant Potential (SUMP) can be made
• Recognize the cytomorphologic features of common bone and soft tissue tumors on fine needle aspiration
• Compare different methodologies used for human papillomavirus (HPV) testing

Intended Audience

Pathologists needing to improve their understanding and confidence in the diagnosis of cytopathology specimens.

+ Topics:

• The Bethesda System for Reporting Thyroid Cytopathology Third Edition – Paul A. VanderLaan, MD, PhD
• Molecular Testing in Thyroid FNA Specimens – Michiya Nishino, MD, PhD
• Thyroid Cytomorphology Part I – Christopher J. VandenBussche, MD, PhD
• Thyroid Cytomorphology Part II – Christopher J. VandenBussche, MD, PhD
• Instructive Thyroid FNA Cases – Christopher J. VandenBussche, MD, PhD
• The Milan System for Reporting Salivary Gland Cytopathology Second Edition – William C. Faquin, MD, PhD
• Instructive Salivary Gland FNA Cases – Zahra Maleki, MD
• FNA of Lateral Neck Lesions – A Case-Based Approach – Darcy A. Kerr, MD
• Approach to Liver Cytopathology and Small Biopsies – M. Lisa Zhang, MD
• Update on the WHO Reporting System for Pancreaticobiliary Cytopathology – Martha Bishop Pitman, MD
• FNA Cytology of Solid Pancreatic Lesions – Monica T. Garcia-Buitrago, MD, FCAP
• Approach to Pancreatic Cyst Cytology – M. Lisa Zhang, MD
• Instructive Pancreas FNA Cases – Christopher J. VandenBussche, MD, PhD
• Serous Cavity I – The International System for Serous Fluid Cytopathology – Ashish Chandra, FRCPath, DipRCPath (Cytol)
• Serous Cavity II – Pleural Fluid – Malignant Tumors and Mimickers – Peter Illei, MD
• Serous Cavity III – Pelvic Washing Specimens – Christopher J. VandenBussche, MD, PhD
• Serous Cavity IV – Challenges Cases – Pelvic Washing Specimens – Christopher J. VandenBussche, MD, PhD
• Bone and Soft Tissue (BST) I – The WHO Reporting System for Soft Tissue Cytopathology – Ivan Chebib, MD, FRCPC
• Bone and Soft Tissue (BST) II – A Pattern-Based Approach – Vickie Y. Jo, MD
• Bone and Soft Tissue (BST) III – An Update on Immunohistochemical Markers – Vickie Y. Jo, MD
• Cytopathology of Bone Tumors – Valerie A. Fitzhugh, MD
• Cytopathology of Soft Tissue Tumors – Valerie A. Fitzhugh, MD
• The International System for Reporting Lung Cytopathology – Fernando Schmitt, MD, PhD, FIAC
• Pulmonary I – Cytology of NSCLC – Does Morphology Matter? – Peter Illei, MD
• Pulmonary II – Lung Tumors other than NSCLC – Peter Illei, MD
• Pulmonary III – Ancillary Testing in NSCLC: Why, When, and How to Perform? – Peter Illei, MD
• Pulmonary IV – Non-Neoplastic Pulmonary Cytology: Bugs, BALs, and Beyond – Peter Illei, MD
• Kidney I – Fine Needle Aspiration and Small Biopsy Specimens – Madelyn Lew, MD
• Kidney II – Fine Needle Aspiration and Small Biopsy Specimens – Madelyn Lew, MD
• Breast I – Introduction to the Yokohama System – Gary Tse, MBBS
• Breast II – Challenging Cases in Breast Cytology – Christine Noga Booth MD
• Urine I – The Paris System for Reporting Urinary Cytology – Christopher J. VandenBussche, MD PhD
• Urine II – Benign and Reactive Findings in Urine Specimens – Christopher J. VandenBussche, MD PhD
• Urine III – Neoplastic Findings in Urine Specimens – Christopher J. VandenBussche, MD PhD
• Urine IV – Instructive Urine Cytology Cases – Madelyn Lew, MD
• Miscellaneous FNA Challenge Cases – Christopher J. VandenBussche, MD PhD
• HPV Biology and Testing in Pap Test Specimens – Michael J. Thrall, MD
• ASCCP Guidelines and the Role of Cytology in Screening – Michael J. Thrall